Endo Sues FDA Over Generic Adrenalin Approvals

By Adam Lidgett · April 9, 2024, 8:35 PM EDT

Endo has filed a lawsuit against federal health regulatory authorities, alleging that they are wrongfully giving the go-ahead for a generic version of the Adrenalin epinephrine injection, asking for a stay...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login